D-0124-2018 Class III Terminated
FDA drug recall D-0124-2018 was initiated by Renaissance Lakewood, LLC on Nov 11, 2017 and is designated Class III. Reason for recall: Superpotent The recall status is terminated (terminated Apr 1, 2020). Affected quantity: 24,569 bags.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 27, 2017
- Initiation Date
- Nov 11, 2017
- Termination Date
- Apr 1, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 24,569 bags
Product description
Fluconazole Injection, USP, 2 mg/mL, a) 50 mL (NDC 336000-261-10) and b) 100 mL (NDC 33600-002-10), Rx Only, Manufactured for: Claris LifeSciences, Inc. North Brunswick, NJ 08902 By: Claris Injectables Ltd., Gujarat, India
Reason for recall
Superpotent
Distribution pattern
Nationwide
Code information
a) A060174 01/13/2018, A060257 02/28/2018, A060692 05/31/2018, A061165 09/30/2018, A0A0143 01/31/2019, A0A0347 03/31/2019, and A0A0424 04/30/2019 ; b) A060027 12/31/2017
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0124-2018
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026